The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer
Yanqing Liu(State Key Laboratory of Pharmaceutical Biotechnology), Xi Chen(Nanjing University), Chihao Zhao(State Key Laboratory of Pharmaceutical Biotechnology), Xiaohong Jiang(State Key Laboratory of Pharmaceutical Biotechnology), Chen Wang(Jiangsu University), Minghui Liu(The University of Texas MD Anderson Cancer Center), Zhen Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhijian Liu(Nanjing Drum Tower Hospital), Fei Yang(State Key Laboratory of Pharmaceutical Biotechnology), Xiaorui Chen(State Key Laboratory of Pharmaceutical Biotechnology), Wu Sun(Tianjin Medical University Cancer Institute and Hospital), Meng Ding(Chinese Academy of Sciences), Rongjie Cheng(State Key Laboratory of Pharmaceutical Biotechnology), Shufang Cui(China Pharmaceutical University), Feng Sun(Microsoft (United States)), Chen‐Yu Zhang(Central South University), Yeting Hong(State Key Laboratory of Pharmaceutical Biotechnology), Hongwei Liang(China Pharmaceutical University), Mengchao Yu(Qingdao University)
Cited by 136
Related Papers
MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells
|Journal of Experimental & Clinical Cancer Research|2012|213
Identification of seven serum microRNAs from a genome‐wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas
|International Journal of Cancer|2012|193
Biofilm microenvironment-responsive nanoparticles for the treatment of bacterial infection
|Nano Today|2022|182
miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1
|Molecular Cancer|2017|176
Comparison of commercial exosome isolation kits for circulating exosomal microRNA profiling
|Analytical and Bioanalytical Chemistry|2018|165